TCTAP 2014

ISU ABXIS CO., LTD.

ISU ABXIS is a biotech company specialized in developing and manufacturing antibody therapeutics. More strong pipelines have been established in using ISU’s competitive specialties in producing of therapeutic proteins from large-scale mammalian cell culture and antibody engineering.

5th FL, C-dong, Global R&D center, 696-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do
+82-31-696-4641
http://www.abxis.com

Booth No. E012

Exhibition Item
Clotinab (Abciximab) is known for one of the most powerful inhibitors of platelet aggregation. Clotinab has been contracted with partner companies of around 30 countries with the best quality.